These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 15036245

  • 1. Production of intracellular IL-1alpha, IL-1beta, and IL-1Ra isoforms by activated human dermal and synovial fibroblasts: phenotypic differences between human dermal and synovial fibroblasts.
    Maret M, Chicheportiche R, Dayer JM, Gabay C.
    Cytokine; 2004 Mar 07; 25(5):193-203. PubMed ID: 15036245
    [Abstract] [Full Text] [Related]

  • 2. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
    Gabay C, Marinova-Mutafchieva L, Williams RO, Gigley JP, Butler DM, Feldmann M, Arend WP.
    Arthritis Rheum; 2001 Feb 07; 44(2):451-62. PubMed ID: 11229477
    [Abstract] [Full Text] [Related]

  • 3. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.
    Higgins GC, Wu Y, Postlethwaite AE.
    J Immunol; 1999 Oct 01; 163(7):3969-75. PubMed ID: 10490999
    [Abstract] [Full Text] [Related]

  • 4. Pre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1).
    Palmer G, Trolliet S, Talabot-Ayer D, Mézin F, Magne D, Gabay C.
    Cytokine; 2005 Jul 21; 31(2):153-60. PubMed ID: 15923123
    [Abstract] [Full Text] [Related]

  • 5. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts.
    Mühlberg T, Heberling HJ, Joba W, Schworm HD, Heufelder AE.
    Invest Ophthalmol Vis Sci; 1997 Apr 21; 38(5):1018-28. PubMed ID: 9112998
    [Abstract] [Full Text] [Related]

  • 6. Action of intracellular IL-1Ra (Type 1) is independent of the IL-1 intracellular signalling pathway.
    Evans I, Dower SK, Francis SE, Crossman DC, Wilson HL.
    Cytokine; 2006 Mar 07; 33(5):274-80. PubMed ID: 16564702
    [Abstract] [Full Text] [Related]

  • 7. The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes.
    Malyak M, Smith MF, Abel AA, Hance KR, Arend WP.
    J Immunol; 1998 Aug 15; 161(4):2004-10. PubMed ID: 9712073
    [Abstract] [Full Text] [Related]

  • 8. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
    Gabay C, Porter B, Fantuzzi G, Arend WP.
    J Immunol; 1997 Dec 15; 159(12):5905-13. PubMed ID: 9550387
    [Abstract] [Full Text] [Related]

  • 9. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
    Arthritis Rheum; 2005 Mar 15; 52(3):759-69. PubMed ID: 15751073
    [Abstract] [Full Text] [Related]

  • 10. Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility.
    Merhi-Soussi F, Berti M, Wehrle-Haller B, Gabay C.
    Cytokine; 2005 Nov 03; 32(3-4):163-70. PubMed ID: 16246569
    [Abstract] [Full Text] [Related]

  • 11. IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact.
    Jungo F, Dayer JM, Modoux C, Hyka N, Burger D.
    Cytokine; 2001 Jun 07; 14(5):272-82. PubMed ID: 11444907
    [Abstract] [Full Text] [Related]

  • 12. Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells: differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids.
    Levine SJ, Wu T, Shelhamer JH.
    J Immunol; 1997 Jun 15; 158(12):5949-57. PubMed ID: 9190949
    [Abstract] [Full Text] [Related]

  • 13. IL-1 receptor antagonist attenuates MAP kinase/AP-1 activation and MMP1 expression in UVA-irradiated human fibroblasts induced by culture medium from UVB-irradiated human skin keratinocytes.
    Wang X, Bi Z, Chu W, Wan Y.
    Int J Mol Med; 2005 Dec 15; 16(6):1117-24. PubMed ID: 16273295
    [Abstract] [Full Text] [Related]

  • 14. Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts.
    Krzesicki RF, Hatfield CA, Bienkowski MJ, McGuire JC, Winterrowd GE, Chapman DL, Berger AE, McEwan RN, Carter DB, Chosay JG.
    J Immunol; 1993 May 01; 150(9):4008-18. PubMed ID: 8473746
    [Abstract] [Full Text] [Related]

  • 15. Direct contact with stimulated T cells induces the expression of IL-1beta and IL-1 receptor antagonist in human monocytes. Involvement of serine/threonine phosphatases in differential regulation.
    Vey E, Dayer JM, Burger D.
    Cytokine; 1997 Jul 01; 9(7):480-7. PubMed ID: 9237810
    [Abstract] [Full Text] [Related]

  • 16. Production of interleukin-1 receptor antagonist isoforms by microglia in mixed rat glial cells stimulated by lipopolysaccharide.
    Pousset F, Palin K, Verrier D, Bristow A, Dantzer R, Parnet P, Lestage J.
    Eur Cytokine Netw; 2000 Dec 01; 11(4):682-9. PubMed ID: 11125314
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a low molecular weight isoform of IL-1 receptor antagonist.
    Malyak M, Guthridge JM, Hance KR, Dower SK, Freed JH, Arend WP.
    J Immunol; 1998 Aug 15; 161(4):1997-2003. PubMed ID: 9712072
    [Abstract] [Full Text] [Related]

  • 18. Rhinovirus regulation of IL-1 receptor antagonist in vivo and in vitro: a potential mechanism of symptom resolution.
    Yoon HJ, Zhu Z, Gwaltney JM, Elias JA.
    J Immunol; 1999 Jun 15; 162(12):7461-9. PubMed ID: 10358201
    [Abstract] [Full Text] [Related]

  • 19. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E, Muga SJ, Locniskar MF, Fischer SM.
    Mol Carcinog; 1999 Apr 15; 24(4):276-86. PubMed ID: 10326864
    [Abstract] [Full Text] [Related]

  • 20. Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis.
    Palmer G, Talabot-Ayer D, Szalay-Quinodoz I, Maret M, Arend WP, Gabay C.
    Eur J Immunol; 2003 Feb 15; 33(2):434-40. PubMed ID: 12645941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.